Regulation of trophoblast cell invasion by Pyruvate Kinase isozyme M2 (PKM2)

被引:11
|
作者
Mejia, Juan F. [1 ]
Hall, Parker [1 ]
Hirschi, Kelsey M. [1 ]
Reynolds, Paul R. [1 ]
Arroyo, Juan A. [1 ]
机构
[1] Brigham Young Univ, Lung & Placenta Res Lab, Dept Physiol & Dev Biol, Provo, UT 84602 USA
关键词
Placenta; PKM2; mTOR; Trophoblast invasion; Hypoxia; INTRAUTERINE GROWTH RESTRICTION; HYPOXIA; PREECLAMPSIA; GLYCOLYSIS; EXPRESSION; RAGE;
D O I
10.1016/j.placenta.2020.10.019
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Pyruvate kinase isozymes M2 (PKM2) protein is a metabolic enzyme that regulates the final step of glycolysis. This enzyme is present in highly proliferating cells and is expressed in the placenta. We recently demonstrated upregulated placental PKM2 during human intrauterine growth restriction (IUGR). Our current objective was to determine PKM2 regulation of trophoblast invasion, trophoblast PKM2 localization as well as mTOR protein expression, and to determine effects of activation of PKM2 during IUGR. Human placental tissues were obtained and analyzed by immunohistochemistry and western blot. Trophoblast cells were cultured in normoxic and hypoxic conditions and real time cell invasion and PKM2 protein were determined during activation (Fructose-6-bisphosphate; FBP6) or inhibition (Shikonin) of PKM2. In vivo studies determined the effects of PKM2 activation on placental and fetal weights. IUGR samples had elevated levels of p-PKM2. Different trophoblast PKM2 localization and expression was observed during normoxia and hypoxia. Decreased trophoblast invasion and PKM2 expression was observed during mTOR inhibition. Protection from decreased placental and fetal weights was observed by PKM2 activation. We conclude that PKM2 regulates trophoblast cell invasion depending on its subcellular location. Our results suggest that PKM2 regulation in trophoblast cells is more directly affected during hypoxia and its expression is regulated by mTOR activity. Additionally, we conclude that activation of PKM2 could reverse and/or rescue the deceased placental and fetal weights observed during IUGR. These results suggest that PKM2 could be a mediator of trophoblast cell invasion and its abundance influences the development of complicated pregnancies like IUGR.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 50 条
  • [21] Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro
    Yuan, Sujuan
    Qiao, Tiankui
    Zhuang, Xibing
    Chen, Wei
    Xing, Na
    Zhang, Qi
    YONSEI MEDICAL JOURNAL, 2016, 57 (06) : 1312 - 1323
  • [22] The M2 isoform of pyruvate kinase (PKM2) contributes to leukemia stem cell persistence by maintaining oxidative homeostasis and promoting glycolysis
    Sturgill, Eric M.
    Guzman, Monica L.
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Aging-related Tumor Suppressor SIRT2 Modulates Cancer Metabolism Through Regulation of Pyruvate Kinase M2 (PKM2)
    Cha, Y. I.
    Park, S.
    Gius, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S126 - S126
  • [24] Pyruvate Kinase M2 (PKM2) Activation in the Podocyte Prevented Subset Differentiation of Glomerular Cells Induced by Diabetes
    Fu, Jialin
    Li, Qian
    Park, Kyoungmin
    Shinjo, Takanori
    Huang, Qian
    Wu, I-Hsien
    King, George L.
    DIABETES, 2024, 73
  • [25] Activation of Mitochondrial Activities by Pyruvate Kinase M2 (PKM2) in Podocytes Improved Glomerular Metabolism and Diabetic Nephropathy
    Fu, Jialin
    Shinjo, Takanori
    St-Louis, Ronald
    Li, Qian
    Park, Kyoungmin
    Yokomizo, Hisashi
    Zaitsu, Yumi
    Yu, Marc Gregory
    Wu, I-Hsien
    Shah, Hetal
    King, George L.
    DIABETES, 2020, 69
  • [26] Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC)
    Li, Run-Ze
    Fan, Xing-Xing
    Shi, Dan-Feng
    Zhu, Guo-Yuan
    Wang, Yu-Wei
    Luo, Lian-Xiang
    Pan, Hu-Dan
    Yao, Xiao-Jun
    Leung, Elaine Lai-Han
    Liu, Liang
    CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (05) : 1851 - 1858
  • [27] Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis
    Xie, Jiansheng
    Dai, Chunyan
    Hu, Xun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (17) : 8987 - 8999
  • [28] M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells
    Liu, Qing
    Liang, Meng
    Liu, Tao
    Vuitton, Lucine
    Zheng, Shutao
    Gao, Xiangpeng
    Lu, Mang
    Li, Xiuling
    Sheyhidin, Ilyar
    Lu, Xiaomei
    TUMOR BIOLOGY, 2016, 37 (02) : 2665 - 2672
  • [29] Pyruvate Kinase Type M2 (PKM2) Is Selectively Expressed and Involved in Survival and Development in Pancreatic Ductal Adenocarcinoma Cells
    Yokoyama, M.
    Shibuya, R.
    Shiroki, T.
    Tanuma, N.
    Tamai, K.
    Yamaguchi, K.
    Tanaka, N.
    Sugamura, K.
    Satoh, K.
    PANCREAS, 2014, 43 (08) : 1427 - 1428
  • [30] Detection of Pyruvate Kinase Isoform M2 (PKM2) in Arterial Wall Cells, Intact Arteries and Human Atherosclerotic Lesions
    Moeke, Cassidy H.
    Padula, Matthew P.
    Beck, Hans C.
    Hansen, Maria Lyck
    Rasmussen, Lars M.
    Davies, Michael J.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : S139 - S139